The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
YB-800, a monoclonal antibody targeting the human neuronal pentraxin receptor (NPTXR), as a potential candidate for the design of a first in class antibody drug conjugate (ADC) as novel therapeutic intervention in gastro-intestinal cancers.
 
Michel Janicot
Employment - Ymmunobio
Leadership - Ymmunobio
Honoraria - Ymmunobio
Consulting or Advisory Role - Ymmunobio
 
Gunther Wennemuth
Honoraria - Ymmunobio
Consulting or Advisory Role - Ymmunobio
 
Mykola Lyndin
No Relationships to Disclose
 
Janine Moyer
No Relationships to Disclose
 
Peter Schiemann
Employment - Ymmunobio
Leadership - Ymmunobio
Stock and Other Ownership Interests - Ymmunobio
Travel, Accommodations, Expenses - Ymmunobio
(OPTIONAL) Uncompensated Relationships - Ymmunobio